Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation

BackgroundLimited data are available on the relationship of disseminated intravascular coagulation (DIC) with mortality in patients receiving extracorporeal membrane oxygenation (ECMO). Thus, we investigated the association of DIC score and antithrombin (AT) III with clinical outcomes in patients un...

Full description

Bibliographic Details
Main Authors: Tae Wan Kim, Ryoung-Eun Ko, Ki Hong Choi, Chi Ryang Chung, Yang Hyun Cho, Jeong Hoon Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1335826/full
_version_ 1827276693808611328
author Tae Wan Kim
Ryoung-Eun Ko
Ki Hong Choi
Chi Ryang Chung
Yang Hyun Cho
Jeong Hoon Yang
Jeong Hoon Yang
author_facet Tae Wan Kim
Ryoung-Eun Ko
Ki Hong Choi
Chi Ryang Chung
Yang Hyun Cho
Jeong Hoon Yang
Jeong Hoon Yang
author_sort Tae Wan Kim
collection DOAJ
description BackgroundLimited data are available on the relationship of disseminated intravascular coagulation (DIC) with mortality in patients receiving extracorporeal membrane oxygenation (ECMO). Thus, we investigated the association of DIC score and antithrombin (AT) III with clinical outcomes in patients undergoing ECMO.MethodsWe analyzed 703 patients who underwent ECMO between January 2014 and May 2022 at Samsung Medical Center. The DIC score was calculated using laboratory findings within 24 h of the ECMO initiation, and ≥ 5 was defined as overt DIC. In addition, the AT III level was measured to identify the correlation with the DIC score.ResultsAmong the study patients, 169 (24.0%) were diagnosed with overt DIC (DIC group) during early maintenance therapy. In-hospital mortality was significantly higher in the DIC group than in the non-DIC group (55.0% vs. 36.5%, p < 0.001). Bleeding events were significantly higher in the group of patients with a DIC score of 7 or 8 than in the other group (20.8% vs. 8.4%, p = 0.038). DIC score negatively correlated with AT III level (r = −0.417, p < 0.001). The predictive performance of AT III for overt DIC had statistical significance with a c-static of 0.81 (95% confidence interval (CI), 0.77–0.84, p < 0.001).ConclusionOvert DIC was associated with higher in-hospital mortality and a tendency to bleed in ECMO patients. Furthermore, AT III plasma levels can easily predict overt DIC in patients undergoing ECMO. These findings suggest that monitoring AT III plasma levels may be important in the management of ECMO.
first_indexed 2024-04-24T07:04:05Z
format Article
id doaj.art-3df35ef88ff94b36b0a1fe522e220eca
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-24T07:04:05Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-3df35ef88ff94b36b0a1fe522e220eca2024-04-22T04:53:00ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-04-011110.3389/fmed.2024.13358261335826Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenationTae Wan Kim0Ryoung-Eun Ko1Ki Hong Choi2Chi Ryang Chung3Yang Hyun Cho4Jeong Hoon Yang5Jeong Hoon Yang6Department of Pulmonary and Critical Care Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of KoreaDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDivision of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaDivision of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaBackgroundLimited data are available on the relationship of disseminated intravascular coagulation (DIC) with mortality in patients receiving extracorporeal membrane oxygenation (ECMO). Thus, we investigated the association of DIC score and antithrombin (AT) III with clinical outcomes in patients undergoing ECMO.MethodsWe analyzed 703 patients who underwent ECMO between January 2014 and May 2022 at Samsung Medical Center. The DIC score was calculated using laboratory findings within 24 h of the ECMO initiation, and ≥ 5 was defined as overt DIC. In addition, the AT III level was measured to identify the correlation with the DIC score.ResultsAmong the study patients, 169 (24.0%) were diagnosed with overt DIC (DIC group) during early maintenance therapy. In-hospital mortality was significantly higher in the DIC group than in the non-DIC group (55.0% vs. 36.5%, p < 0.001). Bleeding events were significantly higher in the group of patients with a DIC score of 7 or 8 than in the other group (20.8% vs. 8.4%, p = 0.038). DIC score negatively correlated with AT III level (r = −0.417, p < 0.001). The predictive performance of AT III for overt DIC had statistical significance with a c-static of 0.81 (95% confidence interval (CI), 0.77–0.84, p < 0.001).ConclusionOvert DIC was associated with higher in-hospital mortality and a tendency to bleed in ECMO patients. Furthermore, AT III plasma levels can easily predict overt DIC in patients undergoing ECMO. These findings suggest that monitoring AT III plasma levels may be important in the management of ECMO.https://www.frontiersin.org/articles/10.3389/fmed.2024.1335826/fulldisseminated intravascular coagulationextracorporeal membrane oxygenationantithrombin IIIbleedingthrombosis
spellingShingle Tae Wan Kim
Ryoung-Eun Ko
Ki Hong Choi
Chi Ryang Chung
Yang Hyun Cho
Jeong Hoon Yang
Jeong Hoon Yang
Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation
Frontiers in Medicine
disseminated intravascular coagulation
extracorporeal membrane oxygenation
antithrombin III
bleeding
thrombosis
title Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation
title_full Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation
title_fullStr Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation
title_full_unstemmed Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation
title_short Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation
title_sort overt disseminated intravascular coagulation and antithrombin iii predict bleeding and in hospital mortality in patients undergoing extracorporeal membrane oxygenation
topic disseminated intravascular coagulation
extracorporeal membrane oxygenation
antithrombin III
bleeding
thrombosis
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1335826/full
work_keys_str_mv AT taewankim overtdisseminatedintravascularcoagulationandantithrombiniiipredictbleedingandinhospitalmortalityinpatientsundergoingextracorporealmembraneoxygenation
AT ryoungeunko overtdisseminatedintravascularcoagulationandantithrombiniiipredictbleedingandinhospitalmortalityinpatientsundergoingextracorporealmembraneoxygenation
AT kihongchoi overtdisseminatedintravascularcoagulationandantithrombiniiipredictbleedingandinhospitalmortalityinpatientsundergoingextracorporealmembraneoxygenation
AT chiryangchung overtdisseminatedintravascularcoagulationandantithrombiniiipredictbleedingandinhospitalmortalityinpatientsundergoingextracorporealmembraneoxygenation
AT yanghyuncho overtdisseminatedintravascularcoagulationandantithrombiniiipredictbleedingandinhospitalmortalityinpatientsundergoingextracorporealmembraneoxygenation
AT jeonghoonyang overtdisseminatedintravascularcoagulationandantithrombiniiipredictbleedingandinhospitalmortalityinpatientsundergoingextracorporealmembraneoxygenation
AT jeonghoonyang overtdisseminatedintravascularcoagulationandantithrombiniiipredictbleedingandinhospitalmortalityinpatientsundergoingextracorporealmembraneoxygenation